Cahill Logo

Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Cahill Represents Initial Purchasers in $1 Billion Notes Offering by Valeant Pharmaceuticals

Date: 01/30/15

Cahill represented Barclays Capital as lead book-running manager and the co-managers in connection with the Rule 144A offering of $1,000,000,000 aggregate principal amount of 5.5% Senior Notes due 2023 by Valeant Pharmaceuticals International, Inc. Proceeds from the offering will be used to refinance existing indebtedness and for general corporate purposes.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com